UCLA Medical Center Division of Hematology/Oncology
Los Angeles, California, United States
Cancer treatment center in Los Angeles, California
100 Medical Plaza Driveway Suite 550 & 555, Los Angeles, CA 90095
About UCLA Medical Center Division of Hematology/Oncology
"Visit the UCLA Health website for coronavirus updates."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at UCLA Medical Center Division of Hematology/Oncology
During the past decade, UCLA Medical Center Division of Hematology/Oncology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at UCLA Medical Center Division of Hematology/Oncology
According to Clinical.Site data, the most researched conditions in "UCLA Medical Center Division of Hematology/Oncology" are
"AML" (1 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "UCLA Medical Center Division of Hematology/Oncology" in a lesser frequency.
Clinical Trials Intervention Types at UCLA Medical Center Division of Hematology/Oncology
Most popular intervention types in "UCLA Medical Center Division of Hematology/Oncology" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Azacitidine" (1 trials), "Cytarabine (Phase 1 only)" (1 trials), "Furosemide (Phase 1 only)" (1 trials), "Lintuzumab-Ac225" (1 trials) and "Spironolactone" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UCLA Medical Center Division of Hematology/Oncology
The vast majority of trials in "UCLA Medical Center Division of Hematology/Oncology" are
2 trials for "All" genders.
Clinical Trials Status at UCLA Medical Center Division of Hematology/Oncology
Currently, there are NaN active trials in "UCLA Medical Center Division of Hematology/Oncology".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in UCLA Medical Center Division of Hematology/Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in UCLA Medical Center Division of Hematology/Oncology, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".